FDA declines to approve novel MDMA therapy to treat PTSD, with ... - CNN
WEBAug 9, 2024 · The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news...
FDA advisers reject MDMA as treatment for PTSD : Shots - Health News - NPR
WEBJun 5, 2024 · A panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic stress disorder found on Tuesday that the available evidence fails to show...
FDA panel rejects first MDMA treatment amid deep concerns ... - NBC News
WEBJun 4, 2024 · A Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA, commonly known as ecstasy or molly, as a treatment for post-traumatic stress disorder, a...
FDA advisers vote against first MDMA therapy to treat PTSD
WEBJun 4, 2024 · A federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.
MDMA Therapy Inches Closer to Approval - The New York Times
WEBSep 14, 2023 · MDMA-assisted therapy seems to be effective in reducing symptoms of post-traumatic stress disorder, according to a study published on Thursday. The research is the final trial conducted by MAPS...
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
WEBAug 9, 2024 · The Food and Drug Administration on Friday declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder, dealing a serious blow to the nascent field of...
Will MDMA's FDA setback derail psychedelic drug research? : Shots ... - NPR
WEBJun 13, 2024 · The psychedelic drug MDMA is near the end of a decades-long effort to enter mainstream medicine but instead of celebrating, supporters now find themselves wondering if the treatment will actually...
MDMA faces FDA panel in bid to become first-of ... - Associated Press News
WEBJun 5, 2024 · WASHINGTON (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream.
Veterans and Lawmakers Lobby in Bipartisan Push for MDMA …
WEBAug 8, 2024 · More than a half century after federal regulators banned most psychedelic compounds, the Food and Drug Administration is nearing a decision on a novel treatment for post-traumatic stress disorder...
With MDMA on Hold, What’s Next for Psychedelics? - Psychiatric …
WEBSeptember 11, 2024. By Heidi Anne Duerr, MPH. Publication. Article. Psychiatric TimesVol 41, Issue 9. The FDA instead issued a CRL for MDMA-assisted psychotherapy for PTSD, requesting an additional phase 3 trial to examine safety and efficacy. Other psychedelic compounds are proceeding with trials for psychiatric conditions.